A detailed history of Seven Eight Capital, LP transactions in Glaukos Corp stock. As of the latest transaction made, Seven Eight Capital, LP holds 16,391 shares of GKOS stock, worth $2.14 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
16,391
Holding current value
$2.14 Million
% of portfolio
0.21%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$89.48 - $118.35 $1.47 Million - $1.94 Million
16,391 New
16,391 $1.94 Million
Q2 2020

Aug 06, 2020

SELL
$28.78 - $46.83 $215,850 - $351,225
-7,500 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$25.53 - $70.14 $191,475 - $526,050
7,500 New
7,500 $231,000
Q3 2019

Nov 14, 2019

SELL
$58.58 - $83.91 $1.31 Million - $1.88 Million
-22,400 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$63.59 - $78.71 $794,875 - $983,874
-12,500 Reduced 35.82%
22,400 $1.69 Million
Q1 2019

May 15, 2019

BUY
$50.75 - $80.54 $1.77 Million - $2.81 Million
34,900 New
34,900 $2.74 Million
Q4 2018

Feb 14, 2019

SELL
$52.18 - $67.93 $876,624 - $1.14 Million
-16,800 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$38.13 - $68.37 $640,584 - $1.15 Million
16,800 New
16,800 $1.09 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.